Learn More
Medchemexpress LLC Benzo[f]quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo- | 118876-58-7 | C12H8N4O6S | 100 MG

Supplier: Medchemexpress LLC HY15068100MG
NBQX is a highly selective and competitive AMPA receptor antagonist with demonstrated neuroprotective and anticonvulsant activity.
- Highly selective and competitive AMPA receptor antagonist.
- Exhibits high affinity for AMPA and kainate binding sites.
- Minimal or no affinity for the glutamate recognition site on the NMDA receptor complex.
- Decreases seizures induced by PTZ.
- Neuroprotective in a focal ischaemia model.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.